CAPRICOR THERAPEUTICS, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-09-30 was $67.21M, a 30298.75% increase year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-06-30 was $1.99M, a 6.78% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $2.29M.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $221.08K, a 88.24% decline year-over-year.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2025 was $237.03M, a 55.61% increase from fiscal 2024.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2024 was $152.32M, a 496.98% increase from fiscal 2023.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2023 was $25.52M, a 431.18% increase from fiscal 2022.
- CAPRICOR THERAPEUTICS, INC. stock issued during period, value, new issues for fiscal 2022 was $4.80M, a 76.19% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2025-12-31 | $237.03M 10-K · filed 2026-03-17 | |
| 2024-12-31 | $152.32M 10-K · filed 2026-03-17 | |
| 2024-09-30 | $67.21M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $1.99M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $2.29M 10-Q · filed 2025-11-10 | |
| 2023-12-31 | $25.52M 10-K · filed 2025-03-26 | |
| 2023-09-30 | $221.08K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $2.13M 10-Q · filed 2024-11-14 | |
| 2022-12-31 | $4.80M 10-K · filed 2024-03-11 | |
| 2022-09-30 | $1.88M 10-Q · filed 2023-11-14 | |
| 2021-12-31 | $20.17M 10-K · filed 2023-03-17 | |
| 2021-09-30 | $6.56M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $1.04M 10-Q · filed 2022-11-10 | |
| 2021-03-31 | $12.58M 10-Q · filed 2022-11-10 | |
| 2020-12-31 | $27.34M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $1.95M 10-Q · filed 2021-11-12 | |
| 2020-06-30 | $19.50M 10-Q · filed 2021-11-12 | |
| 2020-03-31 | $4.46M 10-Q · filed 2021-11-12 | |
| 2019-12-31 | $9.17M 10-K · filed 2021-03-15 | |
| 2019-09-30 | $2.59M 10-Q · filed 2020-11-13 | $5.08M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-06-30 | $543.14K 10-Q · filed 2020-11-13 | $3.54M derived: sum of 4 quarters · filed 2020-11-13 |
| 2019-03-31 | $1.43M 10-Q · filed 2020-11-13 | $5.77M derived: sum of 4 quarters · filed 2020-11-13 |
| 2018-12-31 | $512.05K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $6.71M 10-K · filed 2020-03-27 |
| 2018-09-30 | $1.05M 10-Q · filed 2019-11-08 | $8.97M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-06-30 | $2.78M 10-Q · filed 2019-11-08 | $12.54M derived: sum of 4 quarters · filed 2019-11-08 |
| 2018-03-31 | $2.37M 10-Q · filed 2019-11-08 | |
| 2017-12-31 | $2.77M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-29 | $11.07M 10-K · filed 2019-03-29 |
| 2017-09-30 | $4.62M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-22 | $13.86M 10-K · filed 2018-03-22 |
| 2016-09-30 | $9.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $13.86M derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $3.93M derived: sum of 4 quarters · filed 2017-03-16 |
| 2016-03-31 | $3.93M 10-Q · filed 2016-05-13 | $3.93M derived: sum of 4 quarters · filed 2017-03-16 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | $16.45M 10-K · filed 2017-03-16 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | |
| 2015-03-31 | $16.45M 10-Q · filed 2015-05-13 | |
| 2012-12-31 | $5.00M 10-Q · filed 2014-05-15 | |
| 2011-12-31 | $1.00M 10-Q · filed 2014-05-15 | |
| 2006-12-31 | $3.01M 10-Q · filed 2014-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |